In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
ani pharmaceuticals的4位分析師推薦的深入分析
The perception of ANI Pharmaceuticals by financial experts...ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
ANI Pharmaceuticals（納斯達克：ani pharmaceuticals）在過去三個月裏被4位分析師進行了分析，展示出了從看好到看淡的多種觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $85.5, a high estimate of $94.00, and a low estimate of $60.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 3.66%.
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $85.5, a high estimate of $94.00, and a low estimate of $60.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 3.66%.
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
The perception of ANI Pharmaceuticals by financial experts...
分析師通過最近的...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間